Seòmar agus comataidhean

We know this is a difficult time for travel agents and we have had to make tough decisions to target funding to sectors immediately impacted by the updated public health guidance.

Since the start of the pandemic, businesses have benefitted from more than £4.4bn in support from the Scottish Government. This includes support for travel agents who benefited from sectoral grants of up to £25,000 per premises this year in addition to other support including the Strategic Framework Business Fund grants, Restart Grants, Contingency Fund, Non-Domestic Rates relief and furlough payments for staff.

We recently announced £375m of support for businesses impacted by the necessary public health measures introduced to control the spread of Omicron and have provided details on how £276 million of this will be allocated. Decisions on the allocation of the remaining funds will be confirmed following further consultation with affected sectors on how it can best be targeted.

The Scottish Government used a range of sources of evidence when determining the latest isolation policy changes including data on various key aspects of the pandemic including vaccination rates; clinical advice from senior clinicians including the Chief Medical Officer, PHS public health clinicians, the National Incident Management Team and UKHSA analysis.

In addition, the Scottish Government considered the effects on key workforces and service, including health and social care, of retaining the same isolation policy.

The Scottish Government and NHS recognise the importance of ensuring cervical screening is accessible. Every sample taker is therefore required to undertake training provided by NHS Education for Scotland, and guidance is provided to account for each screening participants needs. This guidance includes making the appropriate adjustments, including those required for disabled women, to ensure that samples can be taken from all eligible women invited for screening. As part of our on-going commitment to providing the best service, in the coming months, the screening programme will explore additional steps to improve the experience for disabled women.

SEPA maintains a robust programme structure to plan, track, and deliver the regulator function for Scotland’s Deposit Return Scheme (DRS), including delivery of a producer registration system. SEPA is making good progress in establishing this system in time to meet the January 2023 milestone that the Scottish Government published in December 2021.

We recognise that the Covid-19 pandemic has had a significant impact on our NHS including diabetes services. We took the opportunity to reflect on these challenges as we determined the priorities for our Diabetes Improvement Plan refresh, which was published in February 2021.

On 25 August 2021 we launched our NHS Recovery Plan which is backed by more than £1bn of investment over the next five years. The plan takes forward our aim of increasing NHS capacity by at least 10% as quickly as possible in order to address the backlog of care and meet the ongoing healthcare needs for people across the country.

The Scottish Government considers a range of data to support policy development. Current data on how Scotland compares to the rest of the UK is considered in the weekly state of the epidemic paper, available on the Scottish Government website. This report ( Coronavirus (COVID-19): state of the epidemic - gov.scot (www.gov.scot) ) brings together the different sources of evidence and data about the COVID epidemic to summarise the current situation, and incorporates data from the UK COVID Dashboard on cases, hospital occupancy and deaths across the four nations. The Scottish Government also refers to the latest data for the four nations from the ONS Covid-19 Infection Survey, which includes estimates of positivity, estimates of the number of people testing positive for antibodies to COVID and long COVID, and has done since the first results were published for Scotland in October 2020.

The evidence and data which informs the Scottish Government is drawn from academic institutions based across the UK which inform SAGE (including via its sub-groups), the UK Health Security Agency and scientific literature from across the world. SAGE includes experts from within government and leading specialists from the fields of healthcare and academia. During the response to the COVID-19 pandemic the SAGE sub groups include:

• New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG)
• Scientific Pandemic Influenza Group on Modelling (SPI-M)
• Independent Scientific Pandemic insights Group on Behaviours (SPI-B)
• COVID-19 Genomics UK (COG-UK)
• Health Data Research UK (HDR UK)

The Heart Disease Action Plan 2021, sets out a strategic vision to address the impact of heart disease across Scotland. This means that the plan does not provide detailed information on specific conditions but instead identifies four priority areas. These are 1) tackling risk factors, 2) ensuring timely and equitable access to diagnosis, treatment and care, 3) addressing key issues within the cardiac workforce, and 4) ensuring effective use of data to support improvement.

The actions within these priority areas should impact across a number of cardiac conditions and therefore improve services for everyone with heart disease, including for people living with heart valve disease.

The Scottish Stroke Care Standards can be found here: ( https://www.strokeaudit.scot.nhs.uk/index.html ). The current standard relating to brain imaging already sets out that 90% of patients should receive this within 12 hours of arrival at first hospital, unless there is a documented contraindication.

The Scottish Stroke Care Standards are regularly reviewed in line with current evidence and updated guidelines. We monitor the implementation of these standards through the Scottish Stroke Care Audit to ensure that stroke patients in Scotland are receiving high quality care.

Further to the answer to question S6W-04701 I can confirm that the case review was undertaken by a small number of NHS Lothian clinicians who are all suitably qualified and experienced in their relevant fields. As none of the clinicians who undertook the review had previously looked after Mr Slorance there was no conflict of interest in undertaking the review.

The Scottish Cardiac Audit Programme, within Public Health Scotland, have been actively seeking data submissions from all sites across Scotland that previously contributed to the UK National Cardiac Audit Programme, managed by the National Institute for Cardiovascular Outcomes Research (NICOR). This includes sites which carry out TAVI procedures.